(Q46948876)

English

A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors

scientific article published on 16 October 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

1 reference

ChEBI release 2020-05-28

2

object named as

Keith Bible

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

author name string

Elisabeth I Heath

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

Robert E Martell

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

Daniel C Adelman

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

Patricia M Lorusso

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

publication date

16 October 2007

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

Investigational New Drugs

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

26

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

59-65

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

https://scigraph.springernature.com/pub.10.1007/s10637-007-9090-3

0 references

Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10637-007-9090-3

21 January 2018

A phase II evaluation of flavopiridol as second-line chemotherapy of endometrial carcinoma: a Gynecologic Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17938863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/17938863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclin E as a prognostic and predictive marker in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17938863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclins and CDKS in development and cancer: lessons from genetically modified mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/17938863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17938863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17938863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17938863

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10637-007-9090-3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/17938863

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46948876&oldid=2139427702"